Morgan Stanley reports 5.3% stake in BlackRock Technology trust
BlackRock Technology & Private Equity Term Trust Schedule 13G reports beneficial ownership by Morgan Stanley and Parametric Portfolio Associates LLC of 6,199,221 common shares, representing 5.3% of the class (CUSIP 09260Q108).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BlackRock Technology & Private Equity Term Trust Schedule 13G reports beneficial ownership by Morgan Stanley and Parametric Portfolio Associates LLC of 6,199,221 common shares, representing 5.3% of the class (CUSIP 09260Q108). The filing attributes shared voting power of 779,668 and shared dispositive power of 6,199,221. Signatures from authorized signatories are dated 05/11/2026. The filing states the holdings reflect certain Morgan Stanley reporting units per Release No. 34-39538.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned financial
Release No. 34-39538 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Morgan Stanley report in BTX?
Does Parametric Portfolio Associates own the same BTX position?
Is this Schedule 13G an acquisition or active trading notice?
What exhibits are attached to the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.